An 81-year-old man with a history of prostate cancer, treated with localized therapy via brachytherapy seeds, presented with right-side flank pain. There was no hematuria and the patient did not have a fever or elevated white count.
CLINICAL HISTORY
An 81-year-old man with a history of prostate cancer, treated with localized therapy via brachytherapy seeds, presented with right-side flank pain. There was no hematuria and the patient did not have a fever or elevated white count.
In 2005, he was treated with ureteroscopy and retrograde pyelography with balloon dilatation and stent insertion for right-side obstruction.
The hydronephrosis resolved, and the patient had been doing well since that time. His past medical history is otherwise unremarkable. The patient’s PSA was normal.
A CT of the abdomen and pelvis was ordered.
FINDINGS
Figure 1: Scout tomogram prior to the CT demonstrates the presence of brachytherapy seeds in the region of the prostate gland and a left hip arthroplasty. No definite opaque calculi are seen projecting over the kidneys or paths of the ureters. Note the single metallic density to the right of and superior to the other cluster of radioactive seeds.
Figure 2: A noncontrast enhanced CT image of the right kidney demonstrates the presence of hydronephrosis (swelling of one kidney due to a backup of urine). No renal calculi are seen. We were able to follow the ureter to the level of the ureterovesical junction (UVJ), and was dilated (not shown).
Figure 3: A noncontrast CT image of the pelvis demonstrates a metallic brachytherapy seed (arrows) lying adjacent to the distal right ureter, superior to and completely separate from the prostate gland. This was a new finding when compared to a prior study (not shown). Incidentally noted is streak artifact from the patient’s hip prosthesis.
DISCUSSION
The patient was scheduled for cystoscopy and right retrograde pyelography/ureteroscopy, with possible balloon dilatation and stent placement.
Dr. Spitzer is associate director of radiology at Montgomery Hospital in Norristown, PA. He can be reached at lspitzer@mont-hosp.com.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.